A detailed history of Woodline Partners LP transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 65,426 shares of VKTX stock, worth $4.12 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
65,426
Previous 65,308 0.18%
Holding current value
$4.12 Million
Previous $5.36 Million 35.24%
% of portfolio
0.03%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$47.39 - $80.2 $5,592 - $9,463
118 Added 0.18%
65,426 $3.47 Million
Q1 2024

May 15, 2024

BUY
$17.4 - $94.5 $1.14 Million - $6.17 Million
65,308 New
65,308 $5.36 Million

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $4.83B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.